ask="N/A"
ask_size="N/A"
average_daily_volume="413640"
bid="84.000"
bid_size="200"
book_value="11.493"
change="-2.545"
change_from_200_day_moving_average="12.518"
change_from_50_day_moving_average="6.527"
change_from_52_week_high="-5.780"
change_From_52_week_low="39.045"
change_in_percent="-2.888%"
close="85.565"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-6.211"
ebitda="-244.58M"
eps_estimate_current_year="-7.110"
eps_estimate_next_quarter="-1.780"
eps_estimate_next_year="-6.450"
ex_dividend_date="N/A"
float_shares="38578000"
high="88.950"
high_52_weeks="91.345"
last_trade_date="3/16/2017"
last_trade_price="85.565"
last_trade_size="30772"
last_trade_time="4:00pm"
low="85.130"
low_52_weeks="46.520"
market_capitalization="3.57B"
moving_average_200_day="73.047"
moving_average_50_day="79.038"
name="Ultragenyx Pharmaceutical Inc."
notes="N/A"
one_year_target_price="93.710"
open="87.670"
pe_ratio="N/A"
peg_ratio="-0.420"
percent_change_from_200_day_moving_average="+17.137%"
percent_change_from_50_day_moving_average="+8.258%"
percent_change_from_52_week_high="-6.328%"
percent_change_from_52_week_low="+83.932%"
previous_close="88.110"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="7.666"
price_per_sales="27642.691"
revenue="133000.00"
shares_outstanding="41726000"
short_ratio="11.260"
stock_exchange="NMS"
symbol="RARE"
volume="362146"
weeks_range_52="46.520 - 91.345"
